Nifty
Sensex
:
:
17327.35
58098.92
-302.45 (-1.72%)
-1020.80 (-1.73%)

Pharmaceuticals & Drugs - Domestic

Rating :
59/99

BSE: 500660 | NSE: GLAXO

1404.25
23-Sep-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 1418.05
  • 1424.80
  • 1397.15
  • 1418.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  61933
  •  872.48
  •  1918.75
  •  1372.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23,788.00
  • 14.03
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 21,303.49
  • 6.41%
  • 8.55

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 0.60%
  • 10.41%
  • FII
  • DII
  • Others
  • 2.16%
  • 10.55%
  • 1.28%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 2.68
  • 0.55

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 8.54
  • 3.00

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 1.66
  • 59.86

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 60.81
  • 61.82
  • 60.78

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.82
  • 13.52
  • 15.37

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 35.41
  • 33.95
  • 31.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
745.10
718.37
3.72%
809.63
744.43
8.76%
815.92
791.87
3.04%
1,009.87
879.32
14.85%
Expenses
596.18
585.65
1.80%
634.41
587.75
7.94%
618.11
611.21
1.13%
733.35
674.46
8.73%
EBITDA
148.92
132.72
12.21%
175.22
156.68
11.83%
197.81
180.66
9.49%
276.52
204.86
34.98%
EBIDTM
19.99%
18.48%
21.64%
21.05%
24.24%
22.81%
27.38%
23.30%
Other Income
27.61
31.73
-12.98%
18.76
29.60
-36.62%
10.32
14.02
-26.39%
14.97
9.04
65.60%
Interest
0.68
0.79
-13.92%
0.28
0.63
-55.56%
0.58
0.94
-38.30%
0.35
0.88
-60.23%
Depreciation
15.82
17.54
-9.81%
15.35
17.68
-13.18%
17.87
17.54
1.88%
17.60
21.96
-19.85%
PBT
160.03
146.12
9.52%
207.85
48.97
324.44%
171.76
186.73
-8.02%
273.54
126.93
115.50%
Tax
43.80
38.84
12.77%
262.51
45.32
479.24%
33.48
47.48
-29.49%
69.30
50.46
37.34%
PAT
116.23
107.28
8.34%
-54.66
3.65
-
138.28
139.25
-0.70%
204.24
76.47
167.09%
PATM
15.60%
14.93%
-6.75%
0.49%
16.95%
17.59%
20.22%
8.70%
EPS
7.04
7.15
-1.54%
71.96
0.85
8,365.88%
8.87
9.24
-4.00%
12.06
4.51
167.41%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Net Sales
3,380.52
3,278.03
2,925.60
3,224.38
3,128.12
2,871.45
2,908.47
2,837.91
3,362.91
2,607.70
2,692.06
Net Sales Growth
7.87%
12.05%
-9.27%
3.08%
8.94%
-1.27%
2.49%
-15.61%
28.96%
-3.13%
 
Cost Of Goods Sold
1,361.53
1,356.19
1,256.86
1,307.87
1,358.03
1,241.31
1,397.75
1,324.90
1,327.66
1,171.68
1,100.57
Gross Profit
2,018.99
1,921.84
1,668.75
1,916.51
1,770.09
1,630.14
1,510.72
1,513.02
2,035.25
1,436.02
1,591.49
GP Margin
59.72%
58.63%
57.04%
59.44%
56.59%
56.77%
51.94%
53.31%
60.52%
55.07%
59.12%
Total Expenditure
2,582.05
2,516.15
2,327.46
2,567.13
2,527.32
2,365.66
2,489.49
2,359.64
2,788.33
2,124.49
1,915.22
Power & Fuel Cost
-
27.83
26.08
33.36
27.94
26.44
27.82
25.97
31.17
23.85
22.50
% Of Sales
-
0.85%
0.89%
1.03%
0.89%
0.92%
0.96%
0.92%
0.93%
0.91%
0.84%
Employee Cost
-
610.23
616.16
628.55
537.20
523.40
483.01
443.37
493.02
362.05
295.52
% Of Sales
-
18.62%
21.06%
19.49%
17.17%
18.23%
16.61%
15.62%
14.66%
13.88%
10.98%
Manufacturing Exp.
-
120.14
110.59
107.89
115.55
110.55
108.26
118.09
367.24
127.78
113.62
% Of Sales
-
3.67%
3.78%
3.35%
3.69%
3.85%
3.72%
4.16%
10.92%
4.90%
4.22%
General & Admin Exp.
-
144.08
117.31
164.51
178.60
204.45
195.08
154.85
178.21
135.34
126.10
% Of Sales
-
4.40%
4.01%
5.10%
5.71%
7.12%
6.71%
5.46%
5.30%
5.19%
4.68%
Selling & Distn. Exp.
-
200.23
124.73
212.36
202.81
154.38
178.91
164.47
222.31
186.23
160.74
% Of Sales
-
6.11%
4.26%
6.59%
6.48%
5.38%
6.15%
5.80%
6.61%
7.14%
5.97%
Miscellaneous Exp.
-
57.45
75.74
112.58
107.20
105.12
98.67
127.99
168.72
117.55
160.74
% Of Sales
-
1.75%
2.59%
3.49%
3.43%
3.66%
3.39%
4.51%
5.02%
4.51%
3.57%
EBITDA
798.47
761.88
598.14
657.25
600.80
505.79
418.98
478.27
574.58
483.21
776.84
EBITDA Margin
23.62%
23.24%
20.45%
20.38%
19.21%
17.61%
14.41%
16.85%
17.09%
18.53%
28.86%
Other Income
71.66
75.78
110.58
79.01
102.32
54.54
73.07
123.18
258.80
222.30
223.90
Interest
1.89
2.00
3.53
6.34
0.55
0.19
0.25
0.42
0.47
0.33
0.33
Depreciation
66.64
68.19
78.60
82.68
48.59
37.99
26.35
24.95
25.35
19.88
17.84
PBT
813.18
767.47
626.59
647.25
653.97
522.17
465.46
576.08
807.56
685.30
982.58
Tax
409.09
398.28
166.72
212.55
237.28
189.24
174.37
202.25
279.27
229.78
272.48
Tax Rate
50.31%
51.12%
36.72%
69.52%
34.76%
35.05%
34.11%
34.97%
36.96%
32.30%
32.66%
PAT
404.09
380.77
287.27
93.20
445.39
350.73
336.81
376.14
476.41
481.67
561.88
PAT before Minority Interest
404.09
380.77
287.27
93.20
445.39
350.73
336.81
376.14
476.41
481.67
561.88
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.95%
11.62%
9.82%
2.89%
14.24%
12.21%
11.58%
13.25%
14.17%
18.47%
20.87%
PAT Growth
23.71%
32.55%
208.23%
-79.07%
26.99%
4.13%
-10.46%
-21.05%
-1.09%
-14.28%
 
EPS
23.85
22.48
16.96
5.50
26.29
20.70
19.88
22.20
28.12
28.43
33.17

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Shareholder's Funds
2,662.96
1,478.26
1,820.60
2,139.83
2,057.33
2,006.86
2,183.25
1,828.98
1,989.73
2,006.83
Share Capital
169.41
169.41
169.41
169.41
84.70
84.70
84.70
84.70
84.70
84.70
Total Reserves
2,493.55
1,308.85
1,651.20
1,970.42
1,972.63
1,922.15
2,098.55
1,744.28
1,905.03
1,922.13
Non-Current Liabilities
158.75
178.68
180.19
2,860.37
2,632.47
3,699.70
3,498.32
197.04
158.59
158.45
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.02
0.18
0.58
0.99
1.60
2.63
3.61
4.14
Long Term Provisions
262.21
259.50
261.74
2,920.20
2,733.36
3,786.83
3,592.19
272.21
242.29
236.05
Current Liabilities
1,698.43
1,354.58
1,021.95
2,804.07
2,948.98
881.09
783.63
1,106.55
888.91
836.40
Trade Payables
570.55
466.13
357.06
405.81
505.86
278.93
327.74
308.04
285.63
237.37
Other Current Liabilities
503.70
450.11
222.85
802.71
842.35
390.47
202.82
130.09
84.13
86.82
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
624.18
438.35
442.04
1,595.54
1,600.77
211.69
253.08
668.42
519.15
512.21
Total Liabilities
4,520.14
3,011.52
3,022.74
7,804.27
7,638.78
6,587.65
6,465.20
3,132.57
3,037.23
3,001.68
Net Block
329.44
385.56
756.59
429.99
322.81
252.71
204.04
123.08
100.09
89.42
Gross Block
606.40
600.65
1,452.35
559.05
405.89
299.09
228.36
363.34
343.22
316.18
Accumulated Depreciation
275.52
215.09
695.76
129.06
83.08
46.38
24.32
240.26
243.13
226.76
Non Current Assets
812.10
808.88
1,247.87
4,445.06
4,103.26
4,752.54
4,087.05
545.58
413.30
355.01
Capital Work in Progress
30.50
13.21
120.12
1,002.64
922.90
605.46
267.67
115.22
61.86
43.79
Non Current Investment
1.21
1.35
1.49
1.69
1.84
5.40
6.04
0.06
0.06
10.06
Long Term Loans & Adv.
445.49
401.71
362.49
3,002.88
2,850.97
3,882.49
3,609.24
296.09
237.73
194.55
Other Non Current Assets
5.45
7.05
7.17
7.84
4.75
6.47
0.06
11.13
13.55
17.19
Current Assets
3,708.03
2,202.64
1,774.88
3,359.21
3,535.52
1,835.10
2,378.15
2,586.98
2,623.94
2,646.67
Current Investments
365.59
0.00
0.00
0.00
0.00
0.00
0.00
0.00
10.00
44.91
Inventories
534.70
546.70
483.03
486.49
500.18
425.80
525.87
375.58
346.97
285.15
Sundry Debtors
205.24
215.60
99.80
120.49
146.96
170.80
126.56
100.32
96.39
115.90
Cash & Bank
2,484.51
1,157.96
1,083.20
1,171.35
1,296.41
899.61
1,391.90
1,910.61
2,041.58
2,066.77
Other Current Assets
118.00
225.89
48.58
112.30
1,591.97
338.90
333.82
200.47
128.99
133.94
Short Term Loans & Adv.
28.40
56.48
60.27
1,468.58
1,513.25
232.20
310.58
112.04
71.19
58.18
Net Current Assets
2,009.60
848.06
752.93
555.14
586.54
954.01
1,594.52
1,480.43
1,735.03
1,810.27
Total Assets
4,520.13
3,011.52
3,022.75
7,804.27
7,638.78
6,587.64
6,465.20
3,132.56
3,037.24
3,001.68

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Cash From Operating Activity
810.75
577.91
490.50
409.49
472.80
234.37
138.90
337.64
281.31
313.59
PBT
2,475.65
723.10
647.25
653.97
522.17
465.46
576.08
807.56
685.30
982.58
Adjustment
-1,636.48
-25.64
13.17
-31.36
-12.17
-46.47
-96.01
-173.66
-156.37
-159.63
Changes in Working Capital
119.87
45.75
44.07
-4.19
164.56
-26.69
-124.41
-36.90
11.45
56.35
Cash after chg. in Working capital
959.04
743.20
704.49
618.41
674.55
392.29
355.67
597.00
540.37
879.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-112.23
-146.95
-179.72
-194.24
-202.01
-160.59
-205.95
-252.43
-244.09
-318.38
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-36.06
-18.34
-34.26
-14.69
0.25
2.67
-10.82
-6.93
0.00
0.00
Cash From Investing Activity
-405.51
418.03
-56.84
-153.45
-104.19
300.64
499.02
180.01
188.98
-109.65
Net Fixed Assets
-23.04
958.61
-10.78
-232.90
-424.24
-408.52
-61.62
-73.47
-45.11
-27.98
Net Investments
-365.45
0.15
0.20
23.26
3.56
0.64
-5.96
10.00
44.92
57.21
Others
-17.02
-540.73
-46.26
56.19
316.49
708.52
566.60
243.48
189.17
-138.88
Cash from Financing Activity
-524.24
-695.56
-427.62
-358.36
-306.63
-510.76
-638.33
-496.99
-494.14
-440.63
Net Cash Inflow / Outflow
-119.00
300.38
6.03
-102.33
61.97
24.24
-0.42
20.66
-23.85
-236.69
Opening Cash & Equivalents
405.19
104.81
98.78
201.10
139.13
114.89
115.30
94.93
137.67
374.36
Closing Cash & Equivalent
286.19
405.19
104.81
98.78
201.10
139.13
114.89
115.59
113.82
137.67

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Book Value (Rs.)
157.19
87.26
107.47
126.31
121.44
118.46
128.88
107.96
117.45
118.46
ROA
10.11%
9.52%
1.72%
5.77%
4.93%
5.16%
7.84%
15.44%
15.95%
18.82%
ROE
18.39%
17.42%
4.71%
21.22%
17.26%
16.08%
18.75%
24.95%
24.10%
28.50%
ROCE
37.72%
27.74%
15.76%
32.54%
26.56%
24.39%
28.82%
39.53%
35.54%
42.24%
Fixed Asset Turnover
5.96
3.04
3.21
6.48
8.21
11.38
9.59
9.82
8.13
8.74
Receivable days
21.34
18.42
12.47
15.60
20.03
18.09
14.59
10.35
14.45
13.29
Inventory Days
54.85
60.14
54.88
57.56
58.36
57.89
57.97
38.01
43.02
40.86
Payable days
139.50
119.53
57.89
73.24
66.07
51.56
53.81
43.72
49.18
47.40
Cash Conversion Cycle
-63.31
-40.97
9.45
-0.07
12.32
24.42
18.75
4.64
8.28
6.75
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
391.29
129.56
49.26
1232.59
2856.45
2045.74
1373.88
1612.26
2146.51
2497.59

News Update:


  • LIC sells 2.04% stake in Glaxosmithkline Pharma
    15th Sep 2022, 10:07 AM

    With this, LIC's shareholding in the company reduced to 4.35 percent

    Read More
  • Glaxosmithkline Pharmaceuticals reports marginal fall Q1 consolidated net profit
    26th Jul 2022, 15:25 PM

    Total consolidated income of the company increased by 3.01% at Rs 772.71 crore for Q1FY23

    Read More
  • Glaxosmithkline Phar - Quarterly Results
    25th Jul 2022, 17:40 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.